Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Simes

Showing results (31-40 of 265) with videos related to

Pageof 27
Sort By:
Seminars in Perinatology|July 8, 2023
To guide future practice, perinatal trials should be much larger, simpler and less fragile with close to 100% ascertainment of mortality and other key outcomesWilliam Odita Tarnow-Mordi, Kristy Robledo, Ian Marschner, et al.
BMJ Open|July 12, 2022
Extrapolating evidence for molecularly targeted therapies from common to rare cancers: a scoping review of methodological guidanceDoah Cho, Saskia Cheyne, Sarah J Lord, et al.
Annals of Internal Medicine|May 7, 2008
Monitoring cholesterol levels: measurement error or true change?Paul P Glasziou, Les Irwig, Stephane Heritier, et al.
JNCI Cancer Spectrum|July 31, 2019
Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced CancerNicola Jane Lawrence, Felicia Roncolato, Andrew Martin, et al.
The Lancet. Oncology|March 3, 2007
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisVal Gebski, Bryan Burmeister, B Mark Smithers, et al.
Lancet (London, England)|October 24, 2006
Correction to the FIELD study reportAnthony Keech, John Simes, Philip Barter, et al.
The Cochrane Database of Systematic Reviews|April 17, 2009
Single agent versus combination chemotherapy for metastatic breast cancerSue Carrick, Sharon Parker, Charlene E Thornton, et al.
BMJ (Clinical Research Ed.)|July 26, 2003
A systematic review of physicians' survival predictions in terminally ill cancer patientsPaul Glare, Kiran Virik, Mark Jones, et al.
Clinical Trials (London, England)|November 26, 2008
Parametric conditional frailty models for recurrent cardiovascular events in the lipid studyJisheng Cui, Andrew Forbes, Adrienne Kirby, et al.
Statistics in Medicine|December 17, 2013
Semiparametric methods for multistate survival models in randomised trialsHarold M Hudson, Serigne N Lô, R John Simes, et al.
Pageof 27

Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
Seminars in Perinatology|July 8, 2023
To guide future practice, perinatal trials should be much larger, simpler and less fragile with close to 100% ascertainment of mortality and other key outcomesWilliam Odita Tarnow-Mordi, Kristy Robledo, Ian Marschner, et al.
BMJ Open|July 12, 2022
Extrapolating evidence for molecularly targeted therapies from common to rare cancers: a scoping review of methodological guidanceDoah Cho, Saskia Cheyne, Sarah J Lord, et al.
Annals of Internal Medicine|May 7, 2008
Monitoring cholesterol levels: measurement error or true change?Paul P Glasziou, Les Irwig, Stephane Heritier, et al.
JNCI Cancer Spectrum|July 31, 2019
Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced CancerNicola Jane Lawrence, Felicia Roncolato, Andrew Martin, et al.
The Lancet. Oncology|March 3, 2007
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisVal Gebski, Bryan Burmeister, B Mark Smithers, et al.
Lancet (London, England)|October 24, 2006
Correction to the FIELD study reportAnthony Keech, John Simes, Philip Barter, et al.
The Cochrane Database of Systematic Reviews|April 17, 2009
Single agent versus combination chemotherapy for metastatic breast cancerSue Carrick, Sharon Parker, Charlene E Thornton, et al.
BMJ (Clinical Research Ed.)|July 26, 2003
A systematic review of physicians' survival predictions in terminally ill cancer patientsPaul Glare, Kiran Virik, Mark Jones, et al.
Clinical Trials (London, England)|November 26, 2008
Parametric conditional frailty models for recurrent cardiovascular events in the lipid studyJisheng Cui, Andrew Forbes, Adrienne Kirby, et al.
Statistics in Medicine|December 17, 2013
Semiparametric methods for multistate survival models in randomised trialsHarold M Hudson, Serigne N Lô, R John Simes, et al.
Pageof 27